We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-0.96%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.02B
AUM Growth
-$472M
Cap. Flow
-$197M
Cap. Flow %
-3.92%
Top 10 Hldgs %
22.58%
Holding
260
New
56
Increased
98
Reduced
45
Closed
43

Top Buys

Rank Stock Value
1
BBNX
Beta Bionics
BBNX
+$91.9M
2
VMC icon
Vulcan Materials
VMC
+$42.6M
3
URI icon
United Rentals
URI
+$42.5M
4
AXON
Axon Enterprise
AXON
+$39.4M
5
GKOS icon
Glaukos
GKOS
+$38.8M

Top Sells

Rank Stock Value
1
ENTG icon
Entegris
ENTG
+$54M
2
TTD icon
Trade Desk
TTD
+$45M
3
MNDY icon
monday.com
MNDY
+$43.8M
4
DTM icon
DT Midstream
DTM
+$42.8M
5
WDAY icon
Workday
WDAY
+$41.9M

Sector Composition

Rank Sector Weight
1 Healthcare 38.88%
2 Technology 18.67%
3 Industrials 15.98%
4 Consumer Discretionary 7.48%
5 Financials 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
101
United Therapeutics
UTHR
$25.8B
$14.6M 0.29%
47,241
-20,584
-30% -$7.05M
SNDX icon
102
Syndax Pharmaceuticals
SNDX
$1.69B
$14.5M 0.29%
1,178,062
– –
FICO icon
103
Fair Isaac
FICO
$24.3B
$14.4M 0.29%
7,834
+66
+0.8% +$122K
KYMR icon
104
Kymera Therapeutics
KYMR
$8.49B
$14.4M 0.29%
525,138
+69,410
+15% +$2.53M
ACAD icon
105
Acadia Pharmaceuticals
ACAD
$4.43B
$14.2M 0.28%
852,845
– –
VITL icon
106
Vital Farms
VITL
$545M
$14.1M 0.28%
463,905
+170
+0% +$6.12K
MKC icon
107
McCormick & Company Non-Voting
MKC
$13.7B
$14.1M 0.28%
+171,051
New +$13.4M
SRPT icon
108
Sarepta Therapeutics
SRPT
$1.57B
$13.7M 0.27%
214,374
-58,580
-21% -$6.17M
BHVN icon
109
Biohaven
BHVN
$2.03B
$13.5M 0.27%
560,056
– –
CHWY icon
110
Chewy
CHWY
$9.25B
$13.5M 0.27%
+413,875
New +$14.8M
XYL icon
111
Xylem
XYL
$27.3B
$13.2M 0.26%
+110,916
New +$13.7M
RVMD icon
112
Revolution Medicines
RVMD
$39.9B
$13.2M 0.26%
372,229
– –
ELS icon
113
Equity Lifestyle Properties
ELS
$12.6B
$13.1M 0.26%
+195,783
New +$13.1M
ROK icon
114
Rockwell Automation
ROK
$53.5B
$13M 0.26%
+50,195
New +$14M
CELC icon
115
Celcuity
CELC
$4.21B
$12.8M 0.25%
1,265,653
– –
IDYA icon
116
IDEAYA Biosciences
IDYA
$3.42B
$12.6M 0.25%
771,844
– –
EWTX icon
117
Edgewise Therapeutics
EWTX
$4.13B
$12.5M 0.25%
+568,310
New +$14.9M
POOL icon
118
Pool Corp
POOL
$6.75B
$12.4M 0.25%
38,919
+801
+2% +$272K
CDW icon
119
CDW
CDW
$18.9B
$12.3M 0.24%
76,701
+1,550
+2% +$282K
GERN icon
120
Geron
GERN
$828M
$11.2M 0.22%
7,072,000
– –
RNAM
121
DELISTED
Avidity Biosciences
RNAM
$11.1M 0.22%
375,924
– –
RLI icon
122
RLI Corp
RLI
$5.62B
$10.3M 0.21%
128,776
-34,378
-21% -$2.62M
LIN icon
123
Linde
LIN
$221B
$10.3M 0.21%
22,177
+2,111
+11% +$950K
WEAV icon
124
Weave Communications
WEAV
$521M
$10.3M 0.21%
928,642
-183,898
-17% -$2.64M
SPGI icon
125
S&P Global
SPGI
$121B
$9.41M 0.19%
18,535
+913
+5% +$467K
3 4
5
6 7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2025 Portfolio in Review

As of Q1 2025, Eventide Asset Management held 260 positions worth $5.02B, down 8.6% from $5.49B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Eventide Asset Management withdrew a net $197M in Q1 2025, closing 43 positions and reducing 45 holdings. Its most notable exit was Iron Mountain, an estimated $39.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 37% a quarter earlier, followed by Technology and Industrials.

Against the trend, Eventide Asset Management opened a new position in Beta Bionics worth $60.3M.

  • Eventide Asset Management's largest Q1 2025 buy was Beta Bionics: 4,928,019 shares worth $60.3M.
  • Eventide Asset Management added most to Inspire Medical Systems in Q1 2025, an estimated $32.8M increase.
  • Eventide Asset Management's biggest Q1 2025 reduction was Entegris, cutting an estimated $54M.
  • Eventide Asset Management fully exited Iron Mountain in Q1 2025, selling an estimated $39.3M.
  • Eventide Asset Management's ten largest holdings make up 23% of its $5.02B portfolio in Q1 2025.
  • Eventide Asset Management opened 56 new positions and closed 43 in Q1 2025.
  • Eventide Asset Management's portfolio value fell 8.6% quarter-over-quarter to $5.02B.

Based on Eventide Asset Management's 13F filing for Q1 2025, filed 15 May 2025.